Management of Helicobacter pylori infection - The Maastricht IV/ Florence consensus report

Peter Malfertheiner, Francis Megraud, Colm A. O'Morain, John Atherton, Anthony T R Axon, Franco Bazzoli, Gian Franco Gensini, Javier P. Gisbert, David Y. Graham, Theodore Rokkas, Emad M. El-Omar, Ernst J. Kuipers, L. P. Andersen, A. Burette, X. Calvet, F. Chan, L. Coelho, J. C. Delchier, F. Di Mario, W. FischbachK. M. Fock, G. Gasbarrini, K. L. Goh, D. Y. Graham, P. Hungin, R. Hunt, V. A. Isakov, M. Kist, S. Koletzko, E. J. Kuipers, L. Kupcinskas, S. Ladas, A. Lanas, M. Leja, J. C. Machado, V. Mahachai, P. Malfertheiner, K. McColl, F. Megraud, Y. Niv, C. O'Morain, A. Pilotto, A. Ristimaki, T. Rokkas, M. Rugge, R. Stockbrügger, K. Sugano, D. Vaira, N. Vakil, M. Vieth

Research output: Contribution to journalArticle

1571 Citations (Scopus)

Abstract

Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.

Original languageEnglish
Pages (from-to)646-664
Number of pages19
JournalGut
Volume61
Issue number5
DOIs
Publication statusPublished - May 1 2012

Fingerprint

Helicobacter Infections
Helicobacter pylori
Infection
Esophageal Diseases
Education
Dyspepsia
Pylorus
Politics
Gastroesophageal Reflux
Routine Diagnostic Tests
Aspirin
Stomach Neoplasms
Anti-Inflammatory Agents
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., ... Vieth, M. (2012). Management of Helicobacter pylori infection - The Maastricht IV/ Florence consensus report. Gut, 61(5), 646-664. https://doi.org/10.1136/gutjnl-2012-302084

Management of Helicobacter pylori infection - The Maastricht IV/ Florence consensus report. / Malfertheiner, Peter; Megraud, Francis; O'Morain, Colm A.; Atherton, John; Axon, Anthony T R; Bazzoli, Franco; Gensini, Gian Franco; Gisbert, Javier P.; Graham, David Y.; Rokkas, Theodore; El-Omar, Emad M.; Kuipers, Ernst J.; Andersen, L. P.; Burette, A.; Calvet, X.; Chan, F.; Coelho, L.; Delchier, J. C.; Di Mario, F.; Fischbach, W.; Fock, K. M.; Gasbarrini, G.; Goh, K. L.; Graham, D. Y.; Hungin, P.; Hunt, R.; Isakov, V. A.; Kist, M.; Koletzko, S.; Kuipers, E. J.; Kupcinskas, L.; Ladas, S.; Lanas, A.; Leja, M.; Machado, J. C.; Mahachai, V.; Malfertheiner, P.; McColl, K.; Megraud, F.; Niv, Y.; O'Morain, C.; Pilotto, A.; Ristimaki, A.; Rokkas, T.; Rugge, M.; Stockbrügger, R.; Sugano, K.; Vaira, D.; Vakil, N.; Vieth, M.

In: Gut, Vol. 61, No. 5, 01.05.2012, p. 646-664.

Research output: Contribution to journalArticle

Malfertheiner, P, Megraud, F, O'Morain, CA, Atherton, J, Axon, ATR, Bazzoli, F, Gensini, GF, Gisbert, JP, Graham, DY, Rokkas, T, El-Omar, EM, Kuipers, EJ, Andersen, LP, Burette, A, Calvet, X, Chan, F, Coelho, L, Delchier, JC, Di Mario, F, Fischbach, W, Fock, KM, Gasbarrini, G, Goh, KL, Graham, DY, Hungin, P, Hunt, R, Isakov, VA, Kist, M, Koletzko, S, Kuipers, EJ, Kupcinskas, L, Ladas, S, Lanas, A, Leja, M, Machado, JC, Mahachai, V, Malfertheiner, P, McColl, K, Megraud, F, Niv, Y, O'Morain, C, Pilotto, A, Ristimaki, A, Rokkas, T, Rugge, M, Stockbrügger, R, Sugano, K, Vaira, D, Vakil, N & Vieth, M 2012, 'Management of Helicobacter pylori infection - The Maastricht IV/ Florence consensus report', Gut, vol. 61, no. 5, pp. 646-664. https://doi.org/10.1136/gutjnl-2012-302084
Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon ATR, Bazzoli F et al. Management of Helicobacter pylori infection - The Maastricht IV/ Florence consensus report. Gut. 2012 May 1;61(5):646-664. https://doi.org/10.1136/gutjnl-2012-302084
Malfertheiner, Peter ; Megraud, Francis ; O'Morain, Colm A. ; Atherton, John ; Axon, Anthony T R ; Bazzoli, Franco ; Gensini, Gian Franco ; Gisbert, Javier P. ; Graham, David Y. ; Rokkas, Theodore ; El-Omar, Emad M. ; Kuipers, Ernst J. ; Andersen, L. P. ; Burette, A. ; Calvet, X. ; Chan, F. ; Coelho, L. ; Delchier, J. C. ; Di Mario, F. ; Fischbach, W. ; Fock, K. M. ; Gasbarrini, G. ; Goh, K. L. ; Graham, D. Y. ; Hungin, P. ; Hunt, R. ; Isakov, V. A. ; Kist, M. ; Koletzko, S. ; Kuipers, E. J. ; Kupcinskas, L. ; Ladas, S. ; Lanas, A. ; Leja, M. ; Machado, J. C. ; Mahachai, V. ; Malfertheiner, P. ; McColl, K. ; Megraud, F. ; Niv, Y. ; O'Morain, C. ; Pilotto, A. ; Ristimaki, A. ; Rokkas, T. ; Rugge, M. ; Stockbrügger, R. ; Sugano, K. ; Vaira, D. ; Vakil, N. ; Vieth, M. / Management of Helicobacter pylori infection - The Maastricht IV/ Florence consensus report. In: Gut. 2012 ; Vol. 61, No. 5. pp. 646-664.
@article{c2a3e28cddcc448a837cb02d6a2ff7cd,
title = "Management of Helicobacter pylori infection - The Maastricht IV/ Florence consensus report",
abstract = "Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.",
author = "Peter Malfertheiner and Francis Megraud and O'Morain, {Colm A.} and John Atherton and Axon, {Anthony T R} and Franco Bazzoli and Gensini, {Gian Franco} and Gisbert, {Javier P.} and Graham, {David Y.} and Theodore Rokkas and El-Omar, {Emad M.} and Kuipers, {Ernst J.} and Andersen, {L. P.} and A. Burette and X. Calvet and F. Chan and L. Coelho and Delchier, {J. C.} and {Di Mario}, F. and W. Fischbach and Fock, {K. M.} and G. Gasbarrini and Goh, {K. L.} and Graham, {D. Y.} and P. Hungin and R. Hunt and Isakov, {V. A.} and M. Kist and S. Koletzko and Kuipers, {E. J.} and L. Kupcinskas and S. Ladas and A. Lanas and M. Leja and Machado, {J. C.} and V. Mahachai and P. Malfertheiner and K. McColl and F. Megraud and Y. Niv and C. O'Morain and A. Pilotto and A. Ristimaki and T. Rokkas and M. Rugge and R. Stockbr{\"u}gger and K. Sugano and D. Vaira and N. Vakil and M. Vieth",
year = "2012",
month = "5",
day = "1",
doi = "10.1136/gutjnl-2012-302084",
language = "English",
volume = "61",
pages = "646--664",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "5",

}

TY - JOUR

T1 - Management of Helicobacter pylori infection - The Maastricht IV/ Florence consensus report

AU - Malfertheiner, Peter

AU - Megraud, Francis

AU - O'Morain, Colm A.

AU - Atherton, John

AU - Axon, Anthony T R

AU - Bazzoli, Franco

AU - Gensini, Gian Franco

AU - Gisbert, Javier P.

AU - Graham, David Y.

AU - Rokkas, Theodore

AU - El-Omar, Emad M.

AU - Kuipers, Ernst J.

AU - Andersen, L. P.

AU - Burette, A.

AU - Calvet, X.

AU - Chan, F.

AU - Coelho, L.

AU - Delchier, J. C.

AU - Di Mario, F.

AU - Fischbach, W.

AU - Fock, K. M.

AU - Gasbarrini, G.

AU - Goh, K. L.

AU - Graham, D. Y.

AU - Hungin, P.

AU - Hunt, R.

AU - Isakov, V. A.

AU - Kist, M.

AU - Koletzko, S.

AU - Kuipers, E. J.

AU - Kupcinskas, L.

AU - Ladas, S.

AU - Lanas, A.

AU - Leja, M.

AU - Machado, J. C.

AU - Mahachai, V.

AU - Malfertheiner, P.

AU - McColl, K.

AU - Megraud, F.

AU - Niv, Y.

AU - O'Morain, C.

AU - Pilotto, A.

AU - Ristimaki, A.

AU - Rokkas, T.

AU - Rugge, M.

AU - Stockbrügger, R.

AU - Sugano, K.

AU - Vaira, D.

AU - Vakil, N.

AU - Vieth, M.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.

AB - Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.

UR - http://www.scopus.com/inward/record.url?scp=84859589351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859589351&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2012-302084

DO - 10.1136/gutjnl-2012-302084

M3 - Article

C2 - 22491499

AN - SCOPUS:84859589351

VL - 61

SP - 646

EP - 664

JO - Gut

JF - Gut

SN - 0017-5749

IS - 5

ER -